Dr. Melissa Johnson, MD

Sarah Cannon Research Institute

Expert in Non-Small Cell Lung Cancer
Expert in Solid Tumors
56 reported clinical trials
83 drugs studied
1 year of experience

About Melissa Johnson, MD


  • Awarded the Morehead-Cain Scholarship at the University of North Carolina, Chapel Hill.
  • Obtained an MD (Doctor of Medicine) from the University of Pennsylvania.


  • Served as Chief Fellow for one year at an unspecified institution.
  • Co-founded the Northwestern Medical Developmental Therapeutics Institute.
  • Since 2014, has been with the Sarah Cannon Research Institute at Tennessee Oncology, now the Associate Director of Lung Cancer Research.
  • Focuses on expanding phase II and III lung cancer clinical trials and developing early-phase compounds for thoracic cancers.

Area of expertise

1Non-Small Cell Lung Cancer
Global Leader
Melissa Johnson, MD has run 29 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
2Solid Tumors
Global Leader
Melissa Johnson, MD has run 21 trials for Solid Tumors. Some of their research focus areas include:
Stage IV
Stage III
ALK positive

Affiliated Hospitals

Image of trial facility.
Sarah Cannon Research Institute
Image of trial facility.
Tennessee Oncology

Clinical Trials Melissa Johnson, MD is currently running

More about Melissa Johnson, MD

Clinical Trial Related1 year of experience running clinical trials · Led 56 trials as a Principal Investigator · 28 Active Clinical Trials
Treatments Melissa Johnson, MD has experience with
  • Pembrolizumab
  • Atezolizumab
  • Nivolumab
  • Docetaxel
  • Carboplatin
  • Osimertinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Melissa Johnson, MD specialize in?
Melissa Johnson, MD focuses on Non-Small Cell Lung Cancer and Solid Tumors. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are metastatic.
Is Melissa Johnson, MD currently recruiting for clinical trials?
Yes, Melissa Johnson, MD is currently recruiting for 26 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Melissa Johnson, MD has studied deeply?
Yes, Melissa Johnson, MD has studied treatments such as Pembrolizumab, Atezolizumab, Nivolumab.
What is the best way to schedule an appointment with Melissa Johnson, MD?
Apply for one of the trials that Melissa Johnson, MD is conducting.
What is the office address of Melissa Johnson, MD?
The office of Melissa Johnson, MD is located at: Sarah Cannon Research Institute, Nashville, Tennessee 37221 United States. This is the address for their practice at the Sarah Cannon Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.